08189 TEDA BIOMEDICAL
Closed Add to Porfolio| Key Financial Ratio (Fiscal Year: 12/2024) | |||
| Current | 0.84X | Oper Margin | N/A |
|---|---|---|---|
| LT Debt/Equity | 106.9% | Net Margin | N/A |
| Total Debt/Equity | 722.0% | Return on Equity | N/A |
| Price/Book | 39.92X | Return on Assets | N/A |
| (HKD 0.495) | 2024-12 | 2023-12 | 2022-12 | 2021-12 | 2020-12 |
| Net Profit (MHKD) | -29.57 | -22.22 | -30.78 | -51.68 | -56.96 |
|---|---|---|---|---|---|
| Net Profit Growth (%) | -33.1 | +27.8 | +40.5 | +9.3 | +39.8 |
| Earnings Per Share (HKD) | -0.016 | -0.012 | -0.016 | -0.027 | -0.03 |
| Earnings Per Share Growth (%) | -33.3 | +27.8 | +40.7 | +9.3 | +39.7 |
| Dividend Per Share (HKD) | No dividend | No dividend | No dividend | No dividend | No dividend |
| P/E* (X) | N/A | N/A | N/A | N/A | N/A |
| Yield (%) | N/A | N/A | N/A | N/A | N/A |
| Dividend Share (%) | N/A | N/A | N/A | N/A | N/A |
| Book NAV (HKD) | 0.012 | 0.029 | 0.042 | 0.065 | 0.090 |
| Auditors' Opinion | Unqualified | Unqualified # | Unqualified | Unqualified | Unqualified |
Remarks:
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
Last Update Time: 2025-07-22 21:40:20
Latest Result
| (RMBMn) | 2024-12 | 2023-12 | Chg* (%) | 2022-12 |
| Cover Period (mths) | 12 | 12 | NA | 12 |
|---|---|---|---|---|
| Turnover | 386.425 | 406.585 | -5.0 | 449.676 |
| Operating Result | -38.166 | -17.417 | +119.1 | -32.406 |
| Associates | 0 | 0 | N/A | 0 |
| Profit Before Taxation | -36.36 | -17.614 | +106.4 | -26.495 |
| Taxation | -0.221 | -1.044 | -78.8 | -0.504 |
| Profit /( Loss) After Taxation | -36.139 | -16.57 | +118.1 | -25.991 |
| Minority Interests | -8.337 | 3.589 | -332.3 | 1.46 |
| Net Profit | -27.802 | -20.159 | +37.9 | -27.451 |
| Earnings Per Share () | -0.0156 | -0.0117 | +33.3 | -0.0162 |
| Announcement Date | 2025-03-31 | 2024-03-28 | NA | 2023-03-30 |
* Annualised
Last Update Time: 2025-07-22 21:40:25
